ImmunoPrecise
在场
ImmunoPrecise 是一家在股票代码 IPA (CA) 下上市的公司。
高管
查看带有其 11 名主要高管的组织结构图
ImmunoPrecise 搜索最多的简介
- Jennifer Bath, Chief Executive Officer and President
- Mitch Levine, Director
- Dirk Witters, Chairman of the Board
创建提醒
跟踪 ImmunoPrecise 的高管变动
生物技术
ImmunoPrecise 拥有 2,332 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- March Biosciences 刚刚宣布为 28 筹款数百万美元。 (公布2024十二月3号).
- Lyell Immunopharma 已收购 ImmPACT Bio (公布2024十一月29号).
- Hopo Therapeutics 刚刚宣布为 226 筹款数百万美元。 (公布2024十一月29号).
生物技术 行业的其他推荐联系人
消息
ImmunoPrecise 的最新新闻稿
- $20 Billion Market Breakthrough: IPA Pioneers High-Impact Antibody Development for Next-Generation ADC Cancer Therapies
- ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
- ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology
- ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024
- ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design
- ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
- ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments
- ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
- ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025
- IPA to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2025 on September 16, 2024
- View more press releases Close
关于 ImmunoPrecise 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Jennifer Bath 
